Jinbao Liu
- Cancer Research top 2%
- Molecular Biology top 2%
- Ubiquitin and proteasome pathways 51
- Histone Deacetylase Inhibitors Research 10
- Protein Degradation and Inhibitors 8
- Biomaterials top 2%
- Cell Biology top 2%
- Endoplasmic Reticulum Stress and Disease 13
- Oncology top 2%
- Peptidase Inhibition and Analysis 19
- Cancer-related Molecular Pathways 12
-
- Autophagy in Disease and Therapy 13
-
- Chronic Myeloid Leukemia Treatments 8
- Journals
- Journal of Biological Chemistry (1 paper)Journal of Clinical Investigation (1 paper)Molecular Cell (1 paper)
- Partner nations
- ChinaUnited StatesSingapore
In The Last Decade
Jinbao Liu
131 papers receiving 6.2k citations
Hit Papers
Peers
Comparison fields: 5 of 149
- Cancer Research 837
- Molecular Biology 3.7k
- Biomaterials 592
- Cell Biology 619
- Oncology 1.0k
Countries citing papers authored by Jinbao Liu
This map shows the geographic impact of Jinbao Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jinbao Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jinbao Liu more than expected).
Fields of papers citing papers by Jinbao Liu
This network shows the impact of papers produced by Jinbao Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jinbao Liu. The network helps show where Jinbao Liu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Jinbao Liu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 1 | |
| 3 | 2025 | 0 | |
| 4 | 2024 | 7 | |
| 5 | 2023 | 6 | |
| 6 | 2023 | 10 | |
| 7 | 2023 | 1 | |
| 8 | 2020 | 21 | |
| 9 | 2020 | 82 | |
| 10 | 2020 | 58 | |
| 11 | 2020 | 50 | |
| 12 | 2020 | 17 | |
| 13 | 2018 | 30 | |
| 14 | AMPK-Mediated BECN1 Phosphorylation Promotes Ferroptosis by Directly Blocking System Xc– Activitybreakdown → | 2018 | 581 |
| 15 | 2018 | 19 | |
| 16 | 2017 | 30 | |
| 17 | 2016 | 1 | |
| 18 | [Relationship between CCL20/CCR6/Th17 axis and vascular invasion and metastasis in patients with primary hepatocellular carcinoma]. | 2015 | 3 |
| 19 | 2013 | 114 | |
| 20 | 2006 | 78 |
About Jinbao Liu
Jinbao Liu is a scholar working on Molecular Biology, Oncology and Hematology, having authored 138 papers that have together received 6.2k indexed citations. Recurring topics across this work include Ubiquitin and proteasome pathways (51 papers), Peptidase Inhibition and Analysis (19 papers), Endoplasmic Reticulum Stress and Disease (13 papers), Autophagy in Disease and Therapy (13 papers), Cancer-related Molecular Pathways (12 papers), Histone Deacetylase Inhibitors Research (10 papers), Chronic Myeloid Leukemia Treatments (8 papers) and Protein Degradation and Inhibitors (8 papers). The work is most often cited by research in Cancer Research (837 citations), Molecular Biology (3.7k citations) and Biomaterials (592 citations). Jinbao Liu has collaborated with scholars based in China, United States and Singapore. Frequent co-authors include Xuejun Wang, Hongbiao Huang, Q. Ping Dou, Kai Zhao, Zheng Jin, Qi Li, Qiuyu Meng, Mo Zhou, Wenqian Wang and Ningning Liu. Their work appears in journals such as Journal of Biological Chemistry, Journal of Clinical Investigation and Molecular Cell.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.